News & Events about Alkermes Plc.
Alkermes plc (NASDAQ:ALKS Get Rating) Research analysts at SVB Leerink lowered their FY2024 earnings estimates for Alkermes in a report released on Wednesday, November 2nd. SVB Leerink analyst M. Goodman now forecasts that the company will earn $0.45 per share for the year, down from their prior ...
Ticker Report
6 months ago
Alkermes (NASDAQ:ALKS Get Rating) had its price target decreased by stock analysts at Mizuho from $36.00 to $34.00 in a research report issued on Thursday, MarketBeat.com reports. The brokerage presently has a buy rating on the stock. Mizuhos price objective points to a ...
Business Wire
8 months ago
Sarissa Capital Management LP (Sarissa) today made the following statement regarding Alkermes plc (NASDAQ: ALKS): Sarissa is disappointed that our discussions with Richard Pops, CEO of Alkermes, regarding the nominations of directors was abruptly ended by the companys sudden announcement of its...
Global Central Nervous System Treatment Market Is Expected to Reach $166 Billion In 2028 Global Central Nervous System Treatment Market Is Expected to Reach $166 Billion In 2028 PR Newswire PALM BEACH, Fla., May 26, 2022 FinancialNewsMedia.com News Commentary PALM BEACH, Fla., May 26, 2022...
Rising Number of Mental Health Disorders Fuel Advancing Initiatives to Reduce Psychiatric and Neurological Conditions Rising Number of Mental Health Disorders Fuel Advancing Initiatives to Reduce Psychiatric and Neurological Conditions PR Newswire PALM BEACH, Fla., March 8, 2022 PALM BEACH, Fla...